Guillain‐Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2018.11.022
Abstract: Immunotherapy with the use of immune checkpoint inhibitors has emerged as a new pillar in cancer therapeutics. Nivolumab is an antibody targeting programmed cell death 1 (PD-1) signaling, which is approved for urothelial cancer treatment… read more here.
Keywords: immune checkpoint; related nivolumab; urothelial cancer; case ... See more keywords